Pathology & Oncology Research

, Volume 25, Issue 2, pp 593–601 | Cite as

Sarcomas of the Oral and Maxillofacial Region: Analysis of 26 Cases with Emphasis on Diagnostic Challenges

  • Priya KumarEmail author
  • Varun Surya
  • Aadithya B. Urs
  • J. Augustine
  • Sujata Mohanty
  • Sunita Gupta
Original Article


Sarcomas of the Oral and Maxillofacial Region (SOMR) are rare lesions which pose diagnostic and management challenges. We analyzed 26 cases of SOMR with respect to clinical presentation, histopathological subtype, treatment modalities, recurrence, and treatment outcome. In our series, Osteosarcoma (OS) was the most common type of sarcoma (7 cases), followed by 5 cases of Ewing’s Sarcoma (ES), 3 cases each of Chondrosarcoma (CS) and Leiomyosarcoma (LMS), 2 cases each of Malignant Peripheral Nerve Sheath Tumor (MPNST), Pleomorphic Undifferentiated Sarcoma (PUS), Myeloid Sarcoma (MS)and Rhabdomyosarcoma (RMS). Surgery was the primary treatment modality in most cases and was combined with adjuvant chemo/ radiotherapy in few cases. 24 of the 26 cases were followed up for an average period of 40.67 months. Adverse disease outcomes like recurrence were seen in 2 cases whereas death due to the disease was reported in 7 cases. In view of the diagnostic challenges faced in SOMRs, it appears practical to stress on the underlying genetic aspects of the disease process rather than histological subtyping to improve disease outcome.


Sarcoma Oral and maxillofacial region Molecular diagnostics 


Compliance with Ethical Standards

As per the institutional guidelines, this study was exempted from ethical clearance.

Conflict of Interest

The authors declare no conflict of interest.

The Precis

After analysis of 26 cases of SOMRs, it is concluded that SOMRs are a diverse group of tumors requiring multimodal treatment and have distinct prognostic implications. From a therapeutic stand point, it is more prudent to stress on the genetic alterations underlying the disease process rather than accurate histological classification to improve prognosis.


  1. 1.
    Kraus DH Sarcomas of the head and neck. Curr Oncol Rep 4:68–75Google Scholar
  2. 2.
    Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D et al (eds) (2002) American joint committee on Cancer: AJCC Cancer staging manual, 6th edn. Springer, New York, pp 77–87Google Scholar
  3. 3.
    Shellenberger T et al (2009) Sarcomas of the head and neck region. Curr Oncol Rep 11:135–142CrossRefGoogle Scholar
  4. 4.
    Tran LM, Mark R, Meier R, Calcaterra TC, Parker RG (1992) Sarcomas of the head and neck . Prognostic factors and treatment strategies. Cancer 70:169–177CrossRefGoogle Scholar
  5. 5.
    O'Neill JP, Bilsky MH, Kraus D (2013) Head and neck sarcomas: epidemiology, pathology, and management. Neurosurg Clin N Am 24(1):67–78CrossRefGoogle Scholar
  6. 6.
    Stavrakas M, Nixon I, Andi K, Oakley R, Jeannon JP, Lyons A, McGurk M, Urbano TG, Thavaraj S, Simo R (2016) Head and neck sarcomas: clinical and histopathological presentation, treatment modalities, and outcomes. J Laryngol Otol 130(9):850–859CrossRefGoogle Scholar
  7. 7.
    Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29CrossRefGoogle Scholar
  8. 8.
    Peng KA, Grogan T, Wang MB (2014) Head and neck sarcomas: analysis of the SEER database. Otolaryngol Head Neck Surg 151(4):627–633CrossRefGoogle Scholar
  9. 9.
    Wanebo HJ, Koness RJ, Macfarlane JK, Eilber FR, Byers RM, Elias EG et al (1992) Head and neck sarcoma: report of the head and neck sarcoma registry. Head Neck 14:1–7CrossRefGoogle Scholar
  10. 10.
    Aljabab A, Nason R, Kazi R, Pathak K (2011) Head and neck soft tissue sarcoma. Indian J Surg Oncol 2:286–290CrossRefGoogle Scholar
  11. 11.
    Arya S, Chaukar D, Pai P (2012) Imaging in oral cancers. Indian J Radiol Imaging 22:195–208CrossRefGoogle Scholar
  12. 12.
    Chaudhary M, Chaudhary SD (2012) Osteosarcoma of jaws. J Oral Maxillofac Pathol 16(2):233–238CrossRefGoogle Scholar
  13. 13.
    Hong HR, Jin S, Koo HJ, Roh JL, Kim JS, Cho KJ, Choi SH, Nam SY, Kim SY (2014) Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI. J Surg Oncol 110(6):696–701CrossRefGoogle Scholar
  14. 14.
    Kumar R, Chauhan A, Vellimana AK, Chawla M (2006) Role of PET/PET-CT in the management of sarcomas. Expert Rev Anticancer Ther 6(8):1241–1250CrossRefGoogle Scholar
  15. 15.
    Wu JS, Hochman MG (2009) Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology 253(2):297–316CrossRefGoogle Scholar
  16. 16.
    Rekhi B, Gorad BD, Kakade AC, Chinoy R (2007) Scope of FNAC in the diagnosis of soft tissue tumors: a study from a tertiary cancer referral Centre in India. Cytojournal 31:4–20Google Scholar
  17. 17.
    Yoshida A, Ushiku T, Motoi T, Beppu Y, Fukayama M, Tsuda H, Shibata T (2012) MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype. Am J Surg Pathol 36(3):423–431CrossRefGoogle Scholar
  18. 18.
    Tabareau-Delalande F, Collin C, Gomez-Brouchet A, Bouvier C, Decouvelaere AV, de Muret A, Pagès JC, de Pinieux G (2014) Chromosome 12 long arm rearrangement covering MDM2 and RASAL1 is associated with aggressive craniofacial juvenile ossifying fibroma and extracranial psammomatoid fibro-osseous lesions. Mod Pathol 28(1):48–56CrossRefGoogle Scholar
  19. 19.
    Argon A, Doğanavşargıl B, ÜnalYıldırım F, Sezak M, Midilli R, Öztop F (2015) Osteosarcomas of jaw: experience of a single Centre. J Plast Surg Hand Surg 49(1):13–18CrossRefGoogle Scholar
  20. 20.
    Yildiz FR, Avci A, Dereci O, Erol B, Celasun B, Gunhan O (2014) Gnathic osteosarcomas, experience of four institutions from Turkey. Int J Clin Exp Pathol 7(6):2800–2808Google Scholar
  21. 21.
    Paparella ML, Olvi LG, Brandizzi D, Keszler A, Santini-Araujo E, Cabrini RL (2013) Osteosarcoma of the jaw: an analysis of a series of 74 cases. Histopathology 63(4):551–557Google Scholar
  22. 22.
    Gomez-Brouchet A, Mourcin F, Gourraud PA, Bouvier C, De Pinieux G, Le Guelec S, Brousset P, Delisle MB, Schiff C (2010) Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma. Hum Pathol 41(9):1220–1230CrossRefGoogle Scholar
  23. 23.
    Unni KK (2001) Cartilaginous lesions of bone. J Orthop Sci 6:457–472CrossRefGoogle Scholar
  24. 24.
    Lee RJ, Arshi A, Schwartz HC, Christensen RE (2015) Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study. JAMA Otolaryngol Head Neck Surg 141(5):470–477CrossRefGoogle Scholar
  25. 25.
    Okada K, Hasegawa T, Yokoyama R et al (2003) Prognostic relevance of rosette-like features in osteosarcoma. J Clin Pathol 56:831–834CrossRefGoogle Scholar
  26. 26.
    Urs AB, Kumar P, Rawat G, Mohanty S (2016) Ewing’s sarcoma of the jaws: an institutional study of four cases. Int J Pediatr Otorhinolaryngol Extra 13:33–39CrossRefGoogle Scholar
  27. 27.
    Lucas DR, Bentley G, Dan ME, Tabaczka P, Poulik JM, Mott MP (2001) Ewing sarcoma vs lymphoblastic lymphoma. A comparative immunohistochemical study. Am J Clin Pathol 115(1):11–17CrossRefGoogle Scholar
  28. 28.
    Yu L, Li M, Lin R, Mu Y, Zhao J (2014) Mesenchymal chondrosarcoma of the right buccal region: a case report and review of the literature. Oncol Lett 8(6):2557–2560. CrossRefGoogle Scholar
  29. 29.
    Wehrli BM, Huang W, De Crombrugghe B, Ayala AG, Czerniak B (2003) Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 34(3):263–269CrossRefGoogle Scholar
  30. 30.
    McKay KM, Deavers MT, Prieto VG (2012) Chondroid melanoma metastatic to lung and skin showing SOX-9 expression: a potential diagnostic pitfall. Int J Surg Pathol 20:169–172CrossRefGoogle Scholar
  31. 31.
    Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC (1986) Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer 15;57(12):2444–2453CrossRefGoogle Scholar
  32. 32.
    Vencio EF, Reeve CM, Unni KK, Nascimento AG (1998) Mesenchymal chondrosarcoma of the jaw bones: clinicopathologic study of 19 cases. Cancer 15;82(12):2350–2355CrossRefGoogle Scholar
  33. 33.
    Yan B, Li Y, Pan J, Xia H, Li LJ (2010) Primary oral leiomyosarcoma: a retrospective clinical analysis of 20 cases. Oral Dis 16(2):198–203CrossRefGoogle Scholar
  34. 34.
    Vilos GA, Rapidis AD, Lagogiannis GD, Apostolidis C (2005) Leiomyosarcomas of the oral tissuses: clinicopathologic analysis of 50 cases. J Oral Maxillofac Surg 63:1461–1477CrossRefGoogle Scholar
  35. 35.
    Nikitakis NG, Lopes MA, Bailey JS, Blanchaert RH Jr, Ord RA, Sauk JJ (2002) Oral leiomyosarcoma: review of the literature and report of two cases with assessment of the prognostic and diagnostic significance of immunohistochemical and molecular markers. Oral Oncol 38(2):201–208CrossRefGoogle Scholar
  36. 36.
    Fisher C (2004) Myofibrosarcoma. Virchows Arch 445(3):215–223CrossRefGoogle Scholar
  37. 37.
    Montgomery E, Fisher C (2001) Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study. Histopathology 38(6):499–509CrossRefGoogle Scholar
  38. 38.
    Perez EA, Kassira N, Cheung MC, Koniaris LG, Neville HL, Sola JE (2011) Rhabdomyosarcoma in children: a SEER population based study. J Surg Res 170(2):e243–ee51CrossRefGoogle Scholar
  39. 39.
    Chen E, Ricciotti R, Futran N, Oda D (2017) Head and neck rhabdomyosarcoma: clinical and pathologic characterization of seven cases. Head Neck Pathol 11(3):321–326CrossRefGoogle Scholar
  40. 40.
    Woodruff JM, Perino G (1994) Non-germ-cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant triton tumor. Semin Diagn Pathol 11:69–81Google Scholar
  41. 41.
    Devesa P, Mitchell TE, Scott I, Moffat D (2006) Malignant peripheral nerve sheath tumors of the head and neck: two cases and a review of the literature. Ear Nose Throat J 85:392–396Google Scholar
  42. 42.
    Cleven AH, Sannaa GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC, Lazar AJ, Bovée JV (2016) Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol 29(6):582–590CrossRefGoogle Scholar
  43. 43.
    Guo A, Liu A, Wei L, Song X (2012) Malignant peripheral nerve sheath tumors: differentiation patterns and Immunohistochemical features - a mini-review and our new findings. J Cancer 3:303–309CrossRefGoogle Scholar
  44. 44.
    Kumar P, Singh H, Khurana N, Urs AB, Augustine J, Tomar R (2017) Diagnostic challenges with intraoral myeloid sarcoma: report of two cases & review of world literature. Exp Oncol 39:78–85CrossRefGoogle Scholar
  45. 45.
    Demicco EG (2013) Sarcoma diagnosis in the age of molecular pathology. Adv Anat Pathol 20(4):264–274CrossRefGoogle Scholar
  46. 46.
    Mariño-Enríquez A, Bovée JVMG (2016) Molecular pathogenesis, diagnostic, prognostic and predictive molecular markers in sarcoma. Surgical pathology clinics 9(3):457–473CrossRefGoogle Scholar
  47. 47.
    Antonescu CR, Owosho AA, Zhang L, Chen S, Deniz K, Huryn JM, Kao YC, Huang SC, Singer S, Tap W, Schaefer IM, Fletcher CD (2017) Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a Clinicopathologic and molecular study of 115 cases. Am J Surg Pathol 41(7):941–949CrossRefGoogle Scholar
  48. 48.
    Bovee JV, Hogendoorn PC (2010) Molecular pathology of sarcomas: concepts and clinical implications. Virchows Arch 456(2):193–199CrossRefGoogle Scholar
  49. 49.
    Casali PG, Jost L, Sleijfer S, Verweij J, Blay JY (2008) Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19(Suppl 2):ii89–ii93Google Scholar
  50. 50.
    Jaetli V, Gupta S (2011) Mesenchymal chondrosarcoma of maxilla: a rare case report. Med Oral Patol Oral Cir Bucal 1;16(4):e493–e496CrossRefGoogle Scholar
  51. 51.
    Gupta SR, Saran RK, Sharma P, Urs AB (2015) A rare case of Extraskeletal mesenchymal chondrosarcoma with dedifferentiation arising from the buccal space in a young male. J Maxillofac Oral Surg 14(Suppl 1):293–299CrossRefGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2018

Authors and Affiliations

  • Priya Kumar
    • 1
    Email author
  • Varun Surya
    • 1
  • Aadithya B. Urs
    • 1
  • J. Augustine
    • 1
  • Sujata Mohanty
    • 2
  • Sunita Gupta
    • 3
  1. 1.Department of Oral PathologyMaulana Azad Institute of Dental SciencesNew DelhiIndia
  2. 2.Department of Oral and Maxillofacial SurgeryMaulana Azad Institute of Dental SciencesNew DelhiIndia
  3. 3.Department of Oral Medicine & RadiologyMaulana Azad Institute of Dental SciencesNew DelhiIndia

Personalised recommendations